CD8A and autoimmune disease: This effect on CD8+T cells is in accordance with recent findings in animal models [28], [29]; indeed IVIg treatment has been reported to decrease in vitro response of antigen specific CD8+T cells, suggesting a similar mechanism in vivo in patients with inflammatory and autoimmune diseases, characterized by self-reactive cytotoxicity [30].